Chetan Karyekar, MD, PhD

VP, late development, immunology at The Janssen Pharmaceutical Companies of Johnson & Johnson.

Articles

The Complementary Role of Real-World Evidence and Clinical Trials in Addressing Unmet Needs for IBD Patients

Patients with Crohn's disease and ulcerative colitis face a high disease burden.